These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 27322236

  • 1. In Vitro Assessment of CYP-Mediated Drug Interactions for Kinsenoside, an Antihyperlipidemic Candidate.
    Rehman SU, Choi MS, Kim IS, Luo Z, Xue Y, Yao G, Zhang Y, Yoo HH.
    Molecules; 2016 Jun 18; 21(6):. PubMed ID: 27322236
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition.
    Dahlinger D, Duechting S, Nuecken D, Sydow K, Fuhr U, Frechen S.
    J Pharmacol Toxicol Methods; 2016 Jun 18; 77():66-75. PubMed ID: 26528794
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Study of in vitro metabolism of m-nisoldipine in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography-mass spectrometry.
    Yuan L, Jia P, Sun Y, Zhao C, Zhi X, Sheng N, Zhang L.
    J Pharm Biomed Anal; 2014 Aug 18; 97():65-71. PubMed ID: 24816159
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone.
    Giri P, Naidu S, Patel N, Patel H, Srinivas NR.
    Eur J Drug Metab Pharmacokinet; 2017 Aug 18; 42(4):677-688. PubMed ID: 27853934
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of nature product kinsenoside analogues with anti-inflammatory activity.
    Song W, Sun Y, Xu L, Sun Y, Li T, Peng P, Lou H.
    Bioorg Med Chem; 2021 Jan 01; 29():115854. PubMed ID: 33223464
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
    Wang Y, Wu S, Chen Z, Zhang H, Zhao W.
    J Ethnopharmacol; 2015 May 26; 166():66-73. PubMed ID: 25764964
    [Abstract] [Full Text] [Related]

  • 17. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.
    Lee KS, Kim SK.
    J Appl Toxicol; 2013 Feb 26; 33(2):100-8. PubMed ID: 21915887
    [Abstract] [Full Text] [Related]

  • 18. Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.
    Dinger J, Meyer MR, Maurer HH.
    Anal Bioanal Chem; 2014 Jul 26; 406(18):4453-64. PubMed ID: 24830396
    [Abstract] [Full Text] [Related]

  • 19. Protection of kinsenoside against AGEs-induced endothelial dysfunction in human umbilical vein endothelial cells.
    Liu Q, Qiao AM, Yi LT, Liu ZL, Sheng SM.
    Life Sci; 2016 Oct 01; 162():102-7. PubMed ID: 27567684
    [Abstract] [Full Text] [Related]

  • 20. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
    Lee SY, Lee JY, Kang W, Kwon KI, Park SK, Oh SJ, Ma JY, Kim SK.
    Food Chem Toxicol; 2013 Jan 01; 51():343-9. PubMed ID: 23104244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.